Recent Posts

Bank of England takes a $100b leap into unknown

Central banks are about to start withdrawing the stimulus they’ve pumped into their economies by buying bonds. For the Bank of England (BOE) in particular, reducing its balance sheet while simultaneously raising interest rates takes monetary policy into uncharted territory. Policy makers could quickly find themselves in the crosshairs, blamed for exacerbating the economic slowdown they’ve forecast. The UK central ...

Read More »

Singapore’s next big challenge is here

To listen to Singapore’s leader, the Bank of England nailed it. The UK central bank’s warning of a tough new era that sent shockwaves through the world of monetary economics resonated in the city-state. The tiny republic that’s staked its survival on the ebbs and flows of global capitalism is girding for a protracted period of slacker growth and a ...

Read More »

GSK’s got heartburn that £50b could probably fix

  Investors are waking up to the risk of litigation against the makers of Zantac, once a blockbuster treatment for heartburn. All of a sudden, GSK Plc’s decision to spin off rather than sell its consumer-healthcare business, Haleon Plc, is looking costly. Haleon, which is behind brands like Sensodyne toothpaste and Panadol painkillers, was a joint venture between GSK, the ...

Read More »
Send this to a friend